MDGL logo

Madrigal Pharmaceuticals (MDGL) Revenue

Annual Revenue

N/A

December 31, 2023


Summary


Performance

MDGL Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMDGLprofitabilitymetrics:

Quarterly Revenue

$62.17 M
+$47.54 M+324.75%

September 30, 2024


Summary


Performance

MDGL Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM Revenue

$76.81 M
+$62.17 M+424.75%

September 30, 2024


Summary


Performance

MDGL TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMDGLprofitabilitymetrics:

MDGL Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-+324.8%+424.8%
3 y3 years-+324.8%+424.8%
5 y5 years-+324.8%+424.8%

MDGL Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+324.8%at high+424.8%
5 y5-yearat high+324.8%at high+424.8%
alltimeall time-52.3%>+9999.0%-46.8%>+9999.0%

Madrigal Pharmaceuticals Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$62.17 M(+324.8%)
$76.81 M(+424.8%)
Jun 2024
-
$14.64 M(+9857.8%)
$14.64 M(+122.2%)
Dec 2012
$147.00 K(-98.1%)
-
-
Mar 2012
-
$147.00 K(-95.7%)
$6.59 M(-13.1%)
Dec 2011
$7.58 M(-48.8%)
$3.42 M(+105.7%)
$7.58 M(-7.5%)
Sep 2011
-
$1.66 M(+22.9%)
$8.20 M(-17.3%)
Jun 2011
-
$1.35 M(+18.5%)
$9.92 M(-16.8%)
Mar 2011
-
$1.14 M(-71.7%)
$11.92 M(-19.5%)
Dec 2010
$14.80 M(-89.7%)
$4.04 M(+19.3%)
$14.80 M(-4.2%)
Sep 2010
-
$3.38 M(+0.7%)
$15.45 M(-89.2%)
Jun 2010
-
$3.36 M(-16.5%)
$142.47 M(-0.9%)
Mar 2010
-
$4.02 M(-14.0%)
$143.76 M(-0.3%)
DateAnnualQuarterlyTTM
Dec 2009
$144.25 M(+5416.1%)
$4.68 M(-96.4%)
$144.25 M(+2.9%)
Sep 2009
-
$130.41 M(+2704.4%)
$140.20 M(+1166.7%)
Jun 2009
-
$4.65 M(+3.1%)
$11.07 M(+42.7%)
Mar 2009
-
$4.51 M(+609.1%)
$7.76 M(+69.2%)
Dec 2008
$2.62 M(+252.0%)
$636.00 K(-50.0%)
$4.58 M(+16.1%)
Sep 2008
-
$1.27 M(-4.9%)
$3.95 M(+47.5%)
Jun 2008
-
$1.34 M(0.0%)
$2.68 M(+100.0%)
Mar 2008
-
$1.34 M(+673.4%)
$1.34 M(+673.4%)
Dec 2007
$743.00 K(+329.5%)
-
-
Dec 2004
$173.00 K(-86.7%)
-
-
Mar 2004
-
$173.00 K
$173.00 K
Dec 2003
$1.30 M
-
-

FAQ

  • What is the all time high annual revenue for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals quarterly revenue?
  • What is the all time high quarterly revenue for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals quarterly revenue year-on-year change?
  • What is Madrigal Pharmaceuticals TTM revenue?
  • What is the all time high TTM revenue for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals TTM revenue year-on-year change?

What is the all time high annual revenue for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high annual revenue is $144.25 M

What is Madrigal Pharmaceuticals quarterly revenue?

The current quarterly revenue of MDGL is $62.17 M

What is the all time high quarterly revenue for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high quarterly revenue is $130.41 M

What is Madrigal Pharmaceuticals quarterly revenue year-on-year change?

Over the past year, MDGL quarterly revenue has changed by +$47.54 M (+324.75%)

What is Madrigal Pharmaceuticals TTM revenue?

The current TTM revenue of MDGL is $76.81 M

What is the all time high TTM revenue for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high TTM revenue is $144.25 M

What is Madrigal Pharmaceuticals TTM revenue year-on-year change?

Over the past year, MDGL TTM revenue has changed by +$62.17 M (+424.75%)